Abstract
Of all the neurotransmitter systems in the brain, dopamine (DA) has been the most widely explored. The reason becomes apparent when one considers the evidence for dopamine involvement in neurological,1 psychiatric,2 and endocrinological function.3
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Bernheimer, H., Birkmayer, W., Hornykiewicz, O., Jellinger, K., and Seitelberger, F., 1973, J. Neurol. Sci. 20:415–455.
Seeman, P., 1977, Biochem. Pharmacol. 26:1741–1748.
Lichtensteiger, W., 1979, The Neurobiology of Dopamine (A. S. Horn, J. Korf, and B. H. C. Westerink, eds.), Academic Press, New York, pp. 491–521.
Ehringer, H., and Hornykiewicz, O., 1960, Klin. Wochenscher. 38:1236–1239.
Birkmayer, W., and Hornykiewicz, O., 1962, Arch. Psychiatr. Nervekr. 203:560–574.
Horn, A. S., Korf, J., and Westerink, B. H. C. (eds.), 1979, The Neurobiology of Dopamine ,Academic Press, New York.
Iversen, L. L., Iversen, S. D., and Snyder, S. H. (eds.), 1975, Handbook of Psychopharmacology ,Volume 3, Plenum Press, New York.
Costa, E., and Greengard, P. (eds.), 1978, Advances in Biochemical Psychopharmacology ,Volume 19, Raven Press, New York.
Van Rossum, J. M., 1966, Arch. Int. Pharmacodyn. Ther. 160:492–494.
Matthysse, S., 1974, J. Psychiatr. Res. 11:107–113.
Nyback, H., Sedvall, G., and Kopin, I. J., 1967, Life Sci. 6:2307–2312.
Gallagher, J. P., Inokuchi, H., and Shinnick-Gallagher, P., 1980, Nature 283:770–772.
Gruen, P. H., Sachar, E. H., Langer, G., Altman, N., Leifer, M., Frantz, A., and Halpern, F. S., 1978, Arch. Gen. Psychiatry 35:108–116.
Kebabian, J. W., Petzold, G. L., and Greengard, P., 1972, Proc. Natl. Acad. Sci. U.S.A. 69:2145–2149.
Iversen, L. L., 1975, Science 188:1084–1089.
Seeman, P., Lee, T., Chau-Wong, M., and Wong K., 1976, Nature 261:717–719.
Creese, I., Burt, D. R., and Snyder, S. H., 1976, Science 192:481–483.
Seeman, P., 1980, Pharmacol. Rev. 32:229–313.
Welsh, J., 1972, Catecholamines (H. Blashko and E. Muscholl, eds.), Springer-Verlag, Berlin, pp. 79–109.
Cottrell, G. A., Berry, M. S., and Macon, J. B., 1974, Neuropharmacology 13:431–439.
Ginsborg, B. L., House, C. P., and Turnbull, K. W., 1976, Br. J. Pharmacol. 57:133–140.
Holzbauer, M., and Sharman, D. F., 1979, The Neurobiology of Dopamine (A. S. Horn, J. Korf, and B. H. C. Westerink, eds.), Academic Press, New York, pp. 357–379.
Lackovic, Z., Relja, M., and Neff, N. H., 1982, J. Neurochem. 38:1453–1458.
Weil-Malherbe, H., and Bone, A. D., 1957, Nature 180:1050.
Carlsson, A., and Waldeck, B., 1958, Acta Physiol. Scand. 44:293–298.
Birkmayer, W., and Hornykiewicz, O., 1961, Wien. Klin. Wochenschr. 73:787–788.
Hokfelt, T., Fuxe, K., and Goldstein, M., 1975, Ann. N.Y. Acad. Sci. 254:407–432.
Bell, C., and Gillespie, J. S., 1981, J. Neurochem. 36:703–706.
Bell, C., 1982, Neuroscience 7:1–8.
Taylor, K., and Laverty, R., 1969, J. Neurochem. 16:1361–1366.
Westerink, B. H. C., and Korf, J., 1977, J. Neurochem. 29:697–706.
Westerink, B. H. C., and Korf, J., 1976, Eur. J. Pharmacol. 38:281–291.
Costa, E., Koslow, S. H., and LeFevre, H. F., 1975, Handbook of Psychopharmacology ,Volume 1 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 1–24.
Coyles, J. T., and Henry, D., 1973, J. Neurochem. 21:61–67.
Ponzio, F., Achilli, G., and Algeri, S., 1981, J. Neurochem. 36:1361–1367.
Westerink, B. H. C., and Mulder T. B. A., 1981, J. Neurochem. 36:1449–1462.
Magnusson, O., Nilsson, R. B., and Westerlund, D., 1980, J. Chromatogr. 221:237–247.
Kempf, E., and Mandel, P., 1981, Anal. Biochem. 112:223–231.
Brownstein, M., Saavedra, J. M., and Palkovits, M., 1974, Brain Res. 79:431–436.
Versteeg, D. H. G., van der Gugten, J., de Jong, W., and Palkovits, M., 1976, Brain Res. 113:563–574.
Falck, B., Hillarp, N. A., Thieme, G., and Torp, A., 1962, J. Histochem. Cytochem. 10:348–354.
Axelsson, S., Bjorklund, A., Falck, B., Lindvall, O., and Svensson, L.-A., 1973, Acta Physiol. Scand. 87:57–62.
Lindvall, O., Bjorklund, A., Hokfelt, T., and Lungdahl, A., 1973, Histochemie 35:31–38.
Anden, N.-E., Carlsson, A., Dahlstrom, A., Fuxe, K., Hillarp, N. A., and Larsson, N., 1964, Life Sci. 3:523–530.
Ungerstedt, U., 1971, Acta Physiol. Scand. [Suppl.] 82:1–93.
Dahlstrom, A., and Fuxe, K., 1964, Acta Physiol. Scand. [Suppl.] 232:1–55.
Lindvall, O., 1975, Brain Res. 87:89–95.
Bjorklund, A., Falck, B., Hromek, F., Owman, C., and West, K. A., 1970, Brain Res. 17:1–23.
Moore, R. Y. and Bloom, F. E. 1978, Ann Rev. Neurosci. 1:129–169.
Udenfriend, S., and Zaltzman-Nirenberg, P., 1963, Science 142:394–396.
Nyback, H., Sedvall, G., Sjoquist, B., and Wiesel, F.-A., 1973, Acta Physiol. Scand. 87:8A–9A.
Kucaenski, R. J., and Mandell, A. J., 1972, J. Biol. Chem. 247:3114–3122.
Besson, M. J., Cheramy, A., Gauchy, C., and Musacchio, J., 1973, Eur. J. Pharmacol. 22:181–186.
Murrin, L. C., Morgenroth, V. H. III, and Roth, R. H., 1976, Mol. Pharmacol. 12:1070–1081.
Goldstein, M., Bronaugh, R. L., Ebstein, B., and Roberge, C., 1976, Brain Res. 109:563–574.
Nowycky, M. C., and Roth, R. H., 1978, Prog. Neuropsychopharmacol. 2:139–158.
Guidotti, A., and Costa, E., 1977, Biochem. Pharmacol. 26:817–823.
Carlsson, A., and Lindqvist, M., 1978, Naunyn Schmiedebergs Arch. Pharmacol. 303:157–164.
Sved, A. F., Fernstrom, J. D., and Wurtman, R. J., 1979, Life Sci. 25:1293–1300.
Roth, R. H., 1979, The Neurobiology of Dopamine (A. S. Horn, J. Korf, and B. H. C. Westerink, eds.), Academic Press, New York, pp. 101–122.
Musacchio, J. M., 1975, Handbook of Psychopharmacology (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 4–10.
Nagatsu, T., Levitt, M., and Udenfriend, S., 1974, J. Biol. Chem. 239:2910–2917.
Waymire, J. C., Bjur, R., and Weiner, N., 1971, Anal. Biochem. 43:588–600.
Sourkes, T. L., 1955, Rev. Can. Biol. 14:49–63.
Sourkes, T. L., 1966, Pharmacol. Rev. 18:53–116.
Carlsson, A., and Lindqvist, M., 1973, J. Neural. Transm. 23:79–91.
De Belleroche, J. S., Bradford, H. F., and Jones, D. G., 1976, J. Neurochem. 26:561–571.
Liang, N. Y., and Rutledge, C. O., 1982, Biochem. Pharmacol. 31:983–992.
Dubocovich, M. L., and Weiner, N., 1981, J. Pharmacol Exp. Ther. 219:710–717.
Giorguieff-Chesselet, M. F., Kemel, M. L., Wandscheer, D., and Glowinski, J., 1979, Eur. J. Pharmacol. 60:101–104.
Roberts, R. J., and Anderson, S. D., 1979, J. Neurochem. 32:1539.
Ennis, C., Kemp, J. D., and Cox, B., 1981, J. Neurochem. 36:1515–1520.
Bustos, G., and Roth, R. H., 1972, Br. J. Pharmacol. 46:101–115.
Holz, R. W., and Coyle, J. T., 1974, Mol. Pharmacol. 10:746–758.
Heikkila, R. E., Orlansky, W., and Cohen, G., 1975, Biochem. Pharmacol. 24:847–852.
Westerink, B. H. C., 1979, The Neurobiology ofDopamine (A. Horn, J. Korf, and B. Westerink, eds.), Academic Press, New York, pp. 225–291.
Westerink, B. H. C., and Spaan, S. J., 1982, J. Neurochem. 38:680–686.
Carlsson, A., and Lindqvist, M., 1963, Acta Pharmacol. Toxicol. 20:140–144.
Anden, N.-E., and Stock, G., 1973, J. Pharm. Pharmacol. 25:346–348.
Bacopoulos, N. G., Heninger, G. R., and Roth, A. H., 1978, Life Sci. 23:1805–1812.
Costall, B., and Naylor, R. J., 1973, Arzneim. Forsch. 23:674–683.
Ezrin-Waters, C., Muller, P., and Seeman, P., 1976, Can. J. Physiol. Pharmacol. 54:516–519.
Snyder, S. H., 1976, Am. J. Psychiatry 133:197–202.
Goodwin, F. K., 1972, Psychiatric Complications of Medical Drugs ,(R. I. Shader, ed.), Raven Press, New York, pp. 149–174.
Smythe, G. A., 1977, Clin. Endocrinol. 7:325–341.
Dill, R. E., Jones, D. L., Christian Gillin, J., and Murphy G., 1979, Pharmacol. Biochem. Behav. 20:711–716.
Niemegeers, C. J. E., Heykants, J. J. P., and Janssen, P. A. J., 1981, Psychopharmacology 75:240–244.
Ungerstedt, U., 1971, Acta Physiol. Scand. [Suppl.] 367:69–93.
Ungerstedt, U., 1971, Ibid 49–68.
Corrodi, H., Farnebo, L., Fuxe, K., Hamberger, B., and Ungerstedt, U., Eur. J. Pharmacol. 20:195–201.
Siggins, G. R., 1978, Psychopharmacology: A Generation of Progress (M. A. Lipton, A. Di Mascio, and K. F. Killam, eds.), Raven Press, New York, pp. 143–157.
Feltz, P., and De Champlain, J., 1972, Brain Res. 43:601–605.
Herz, A., and Zieglgansberger, W., 1968, Int. J. Neuropharmacol. 7:221–230.
York, D.-H., 1975, Handbook of Psychopharmacology ,Volume 6 (L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 23–61.
Kebabian, J. W., and Calne, D. B., 1979, Nature 277:93–96.
Brown, E. H., Carroll, R. J., and Aurbach, G.D., 1977, Proc. Natl. Acad. Sci. U. S. A. 74:4210–4213.
Sokoloff, P., Martres, M. P., and Schwartz, J. C., 1980, Naunyn Schmiedebergs Arch. Pharmacol. 315:89–102.
Goldberg, L. I., and Kohli, J. D., 1979, Commun. Psychopharmacol. 3:447–456.
Leysen, J. E., and Gommeren, W., 1978, Life Sci. 23:447–452.
Kebabian, J. W., and Greengard, P., 1971, Science 174:1346–1349.
Stoof, J. C., Kebabian, J. W., 1981, Nature 294:366–368.
Hyttel, J., 1980, Psychopharmacology 67:107–109.
Cross, A. J., and Owen, F., 1980, Eur. J. Pharmacol. 65:341–347.
Hyttel, J., 1978, Life Sci. 23:551–556.
Garau, L., Govoni, S., Stefanini, E., Trabucchi, M., and Spano, P. F., 1978, Life Sci. 23:1745–1750.
Minneman, K. P., Quik, M., and Emson, P. C., 1978, Brain Res. 151:507–521.
Cannon, J. G., Costall, B., Laduron, P. M., Leysen, J. E., Naylor, R. J., 1978 Biochem. Pharm. 27:1417–1420.
Iversen, L. L., Horn, A. S., and Miller, R. J., 1975, Adv. Neurol. 9:197–212.
Markstein, A. M., Herrling, P. L., Burki, H. R., Asper, H., and Ruch, W., 1978, J. Neurochem. 31:1163–1172.
Pagnini, G., Camanni, F., Crispino, A., and Portaleone, P., 1978, J. Pharm. Pharmacol. 30:92–95.
Leysen, J., and Laduron, P., 1977, Life Sci. 20:281–288.
Quik, M., and Iversen, L. L., 1979, Eur. J. Pharmacol. 56:323–330.
Watling, K. J., Dowling, J. E., and Iversen, L. L., 1979, Nature 281:578–580.
Tassin, J. P., Simon, H., Herve, D., Blanc, G., Le Moal, M., and Bockaert, J., 1982, Nature 295:696–698.
Church, A. C., Bunney, B. S., and Krieger, N. R., 1982, Brain Res. 234:369–376.
Hartley, E., Spuhler, K., Prasad, K. N., and Seeman, P., 1980, Brain Res. 190:574–577.
Premont, J., Thierry, A. M., Tassin, J. P., Glowinski, J., Blanc, G., and Bockaert, J., 1976, FEBS Lett. 68:99–104.
McSwigon, J. D., Nichol, S. E., Gottesman, I. I., Tuason V. B., and Frey, W. H. II, 1980, J. Neurochem. 34:594–601.
Thomas, T. N., and Zemp, J. W., 1977, J. Neurochem. 28:663–665.
Kayaalp, S. O., Rukensteen, J. S., and Neff, N. H., 1981, Neuropharmacology 20:409–410.
Madras, B. K., Davis, A., Chan, B., and Seeman, P., 1981, Prog. Neuropyschopharmacol. 5:543–548.
Madras, B. K., and Chan, B., 1983, CNS Receptors, From Molecular Pharmacology to Behavior. (P. Mandel and F. V. DeFeudis, eds.), Raven Press, pp. 275–287.
Heikilla, R. E., Cabbat, F. S., and Manzino, L., 1981, Res. Commun. Chem. Pathol. Phar macol. 34:409–421.
Kebabian, J. W., 1978, Adv. Biochem. Psychopharmacol. 19:131–154.
Lee, T., Seeman, P., Tourtellotte, W. W., Farley, I. J., and Hornykiewicz, O., 1978, Nature 274:897–900.
Crow, T. J., Johnstone, E. C., Longden, A. J., and Owen, F., 1978, Life Sci. 23:563–568.
Peroutka, S. J., U’Prichard, D. C., Greenberg, D. A., and Snyder, S. H., 1977, Neuropharmacology 16:549–556.
Leysen, J. E., Niemegeers, C. J. E., Tollenaere, J. P., and Laduron P. M., 1978, Nature 272:168–171.
Seeman, P., Westman, K., Coscina, D., and Warsh, J. J., 1980, Eur. J. Pharmacol. 66:179–191.
Quik, M., and Iversen, L. L., 1979, Eur. J. Pharmacol. 56:323–330.
Seeman, P., Chau-Wong, M., Tedesco, J., and Wong, D., 1975, Proc. Natl. Acad. Sci. U.S.A. 72:4376–4380.
Spedding, M., and Berg, C., 1982, J. Pharm. Pharmacol. 34:56–58.
List, S., and Seeman, P., 1981, Proc. Natl. Acad. Sci. U.S.A. 78:2620–2624.
Quik, M., Iversen, L. L., Larder, A., and Mackay, A. V. P., 1978, Nature 274:513–514.
Baudry, M., Martres, M. P., and Schwartz, J. C., 1979, Naunyn Schmiedebergs Arch. Pharmacol. 308:231–237.
Lazareno, S., Nahorski, S. R., 1981, Br. J. Pharmacol. 74:231P–232P.
Freedman, S. B., Poat, J. A., and Woodruff, G. N., 1981, Neuropharmacology 20:1323–1326.
Jenner, P., and Marsden, C. D., 1981, Neuropharmacology 20:1285–1293.
Theodourou, A. E., Hall, M. D., Jenner, P., and Marsden, C. D., 1980, J. Pharm. Pharmacol. 32:441–444.
Seeman, P., Ulpian, C., and Wells, J., 1982, Soc. Neurosci. Abstr. 8:718.
Sibley, D. R., DeLean, A., and Creese, I., 1982, J. Biol. Chem. 257:6351–6361.
Stefanini, E., and Clement-Cormier, Y. C., 1981, Eur. J. Pharmacol. 74:257–260.
Thai, L., Mishra, R. K., Gardner, E. L., Horowitz, S. G., Varmuza, S., and Makman, M. H., 1979, Brain Res. 170:381–386.
Murrin, L. C., Gale, K., and Kuhar, M. J., 1979, Eur. J. Pharmacol. 60:229–235.
Schwarcz, R., Creese, I., Coyle, J. T., and Snyder, S. H., 1978, Nature 271:766–768.
Sibley, D. R., and Creese, I., 1980, Endocrinology 107:1405–1409.
George, S. R., Watanabe, M., and Seeman, P., 1983, in, Dopamine Receptors (C. Kaiser and J. Kebabian, eds.) American Chemical Society, Washington, D.C., pp 93–99.
Creese, I., Usdin, T., and Snyder, S. H., 1979, Nature 278:557–578.
Hamblin, M. W., and Creese, I., 1982, Mol. Pharmacol. 21:52–56.
Leslie, F. H., Dunlop, C. E., and Cox, B. M., 1980, J. Neurochem. 34:219–221.
Heikilla, R. E., Cabbat, F. S., and Manzino, L., 1982, J. Neurochem. 38:1000–1006.
Muakkassah-Kelly, S. F., Andersen, J. W., Shih, J. C., and Hochstein, P., 1982, Biochem. Biophys. Res. Commun. 104:1003–1010.
Tolbert, L. C., Thomas, T. N., Middaugh, J. D., and Zemp, J. W., 1979, Brain Res. Bull. 4:43–48.
Hamblin, M. W., and Creese, I., 1982, Life Sci. 30:1587–1595.
Meltzer, H. Y., and So, R., 1979, Life Sci. 25:531–536.
Muller, E. E., Stefanini, E., Camanni, F., Locatelli, V., Massara, F., Spano, P. F., and Cochi, D., 1979, J. Neural Transm. 46:205–214.
Cronin, M. J., and Weiner, R. I., 1979, Endocrinology 104:307–312.
Laduron, P. M., Janssen, P. F. M., and Leysen, J. E., 1978, Biochem. Pharmacol. 27:317–321.
Köhler, C., Fuxe, K., and Ross, S. B., 1981, Eur. J. Pharmacol. 72:397–402.
Klemm, N., Murrin, L. C., and Kuhar, M. J., 1979, Brain Res. 169:1–9.
Nomura, Y., Oki, K., and Segawa, T., 1982, J. Neurochem. 38:902–908.
Govoni, S., Spano, P. F., and Trabucchi, M., J. Pharm. Pharmacol. 30:448–449.
Titeler, M., List, S., and Seeman, P., 1980, Commun. Psychopharmacol. 3:411–420.
List, S. J., and Seeman, P., 1982, J. Neurochem. 39:1363–1373.
Arana, G. W., Baldessarini, R. J., and Harding M., 1981, Biochem. Pharmacol. 30:3171–3179.
Sokoloff, P., Martres, M.-P., and Schwartz, J.-C., 1980, Nature 288:283–286.
Davis, A., Madras, B. K., and Seeman, P., 1982, Biochem. Pharmacol. 31:1183–1187.
Leff, S., Sibley, D. R., Hamblin, M., and Creese, I., 1982, Life Sci. 29:2081–2090.
Arana, G. W., Baldessarini, R. J., and Kula, N. S., 1982, Neuropharmacology 21:601–604.
Bacopoulos, N. G., 1981, Life Sci. 23:2407–2414.
Nagy, J. I., Lee, T., Seeman, P., and Fibiger, H. C., 1978, Nature 274:278–281.
Leff, S. E., Hamblin, M. W., and Creese, I., 1982, Soc. Neurosci. Abstr. 8:719.
Nishikori, K., Noshiro, O., Sano, K., and Maeno, H., 1980, J. Biol. Chem. 255:10909–10915.
Madras, B. K., Davis, A., and Seeman, P., 1980, Soc. Neurosci. Abstr. 6:240:
Titeler, M., 1981, Biochem. Pharmacol. 30:3031–3037.
Hamblin, M. W., and Creese, I., 1982, Mol. Pharmacol. 21:44–51.
Lorez, H. P., and Burkard, W. P., 1979, Experientia 35:938.
Marchais, D., Tassin, J. P., and Bockaert, J., 1980, Brain Res. 183:235–240.
Titeler, M., and Seeman, P., 1978, Experientia 34:1490–1493.
Lee, T., and Seeman, P., 1979, Soc. Neurosci. Abstr. 5:653.
Peroutka, S. J., and Snyder, S. H., 1980, Am. J. Psychiatry 137:1518–1522.
Creese, I., Burt, D. R., and Snyder, S. H., 1978, Handbook of Psychopharmacology ,(L. L. Iversen, S. D. Iversen, and S. H. Snyder, eds.), Plenum Press, New York, pp. 37–89.
Seeman, P., Wong, M., and Tedesco, J., 1975, Soc. Neurosci. Abstr. 1:405.
Madras, B. K., Davis, A., and Seeman, P., 1982, Eur. J. Pharmacol. 78:431–438.
Davis, A., Madras, B., and Seeman, P., 1981, Eur. J. Pharmacol. 70:321–329.
Hartley, E. J., and Seeman, P., 1978, Life Sci. 23:513–518.
Creese, I., Stewart, K., and Snyder, S. H., 1979, Eur. J. Pharmacol. 60:55–66.
Caron, M. C., Beaulieu, M., Raymond, V., Gagne, B., Drouin, J., Lefkowitz, R. J., and Labrie, F., 1978, J. Biol. Chem. 253:2244–2253.
Limbird, L. E., Gill, D. M., and Lefkowitz, R. J., 1980, Proc. Natl. Acad. Sci. 77:775–779.
De Lean, A., Kilpatrick, B. F., and Caron, M. G., 1982, Endocrinology 110:1064–1066.
George, S. R., Wregget, K. A., and Seeman, P., 1982, Soc. Neurosci. Abstr. 8:720.
Onali, P., Schwartz, J. P., and Costa, E., 1981, Proc. Natl. Acad. Sci. U.S.A. 78:6531–6534.
Cote, T. E., Greive, C. W., Tsuruta, K., Stoof, J. C., Eskay, R. L., and Kebabian, J. W., 1982, Endocrinology 110:812–819.
Brown, J. H., and Makman, M. H., 1972, Proc. Natl. Acad. Sci. U.S.A. 69:539–543.
Brown, J. H., and Makman, M. H., 1973, J. Neurochem. 21:447–479.
Makman, M. H., Dvorkin, B., Horowitz, S. G., and Thal, L. J., 1980, Brain Res. 194:403–418.
Demenge, P., Mouchet, P., Guerin, B., and Feuerstein, C., 1981, J. Neurochem. 37:53–59.
Goldberg, L. I., Volkman, P. H., and Kohli, J. D., 1978, Annu. Rev. Pharmacol. Toxicol. 18:57–79.
Goldberg, L. I., and Toda, N., 1975, Circ. Res. 36:197–1102.
Toda, N., and Goldberg, L. I., 1975, Cardiovasc. Res. 9:384–89.
Goldberg, L. I., Kohli, J. D., Katake, A. N. and Volkman, P. H. 1978, Fed. Proc. 37:2396–2402.
Goldberg, L. I., Kohli, J. D., Kotake, A. N., and Volkman, P. H., 1977, Adv. Biochem. Pharmacol. 16:251–256.
Attie, M. F., Brown, E. M., Gardner, D. G., Spiegel, A. M., and Aurbach, G. D., 1980, Endocrinology 107:1776–1781.
Lee, T., and Seeman, P., 1980, Am. J. Psychiatry 137:191–197.
Owen, F., Crow, T. J., Poulter, M., Longden, A., and Riley, G. J., 1978, Lancet 2:223–226.
Cross, A. J., Crow, T., and Owen, F., 1981, Psychopharmacology 74:122–124.
Mackay, A. V. P., Bird, E. D., Spokes, E. G., Rosser, M., Iversen L. L., Creese, I., and Snyder, S. H., 1980, Lancet 2:915–916.
Olsen, R. W., Reisine, T. D., and Yamamura, H. I., 1980, Life Sci. 27:801–808.
Ezrin-Waters, C., Seeman, M. V., and Seeman, P., 1981, J. Clin. Psychiatry 42:16–22.
Baldessarini, R. J., and Tarsy, D., 1981, Annu. Rev. Neurosci. 3:23–41.
Tarsy, D., 1983, Clin. Neuropharmacology 6:91–99.
Richardson, M. A., and Craig, T. J., 1982, Am. J. Psychiatry 139:341–343.
Lee, T., Seeman, P., Rajput, A., Farley, I. J., and Hornykiewicz, O., 1978, Nature 278:59–61.
Rinne, U. K., Sonninen, V., and Laaksonen, H., 1979, Adv. Neurol. 24:259–274.
Reisine, T. D., Fields, J. Z., Yamamura, H. I., Bird, E. D., Spokes, E., Schreiner, P. S., and Enna, S. J., 1977, Life Sci. 21:335–344.
Hyttel, J., 1979, J. Neurochem. 33:641–646.
Tarsy, D., and Baldessarini, R. J., 1977, Biol. Psychiatry 12:431–450.
Costall, B., Naylor, R. J., and Owen, R. T., 1978, Eur. J. Pharmacol. 48:29–36.
Seeman, P., and List, S., 1982, Advances in Pharmacology and Therapeutics 11 ,Volume 2, (H. Yoshida, Y. Hagihara, and E. Ebashi, eds.), Pergamon Press, New York.
Baldessarini, R. J., and Tarsy, D., 1979, Int. Rev. Neurobiol. 2:1–45.
Scatton, B., 1977, Eur. J. Pharmacol. 46:363–369.
Muller, P., and Seeman, P., 1977, Life Sci. 21:1751–1758.
Owen, F., Cross, A. J., Waddington, J. L., Poulter, M., Gamble, S. J., and Crow, T. J., 1980, Life Sci. 26:55–59.
Hitri, A., Weiner, W. J., Borison, R. L., Diamond, B. I., Nausieda, P., and Klawans, H. L., 1978, Ann. Neurol. 3:134–140.
Fuxe, K., Ogren, S.-O., Hall, H., Agnati, L. F., Jonsson, G., and Gustafsson, J.-A., 1980, Adv. Biochem. Psychopharmacol. 24:193–206.
Cross, A. J., Crow, T. J., and Owen, F., 1979, Br. J. Pharmacol. 64:87P–88P.
Friend, W. C., Brown, G. M., Jawahir, G., Lee, T., and Seeman, P., 1978, Am. J. Psychiatry 135:839–841.
Thornburg, J. E., and Moore, K. E., 1975, J. Pharmacol. Exp. Ther. 192:42–49.
Skirboll, L. R., and Bunney, B. S., 1979, Life Sci. 25:1419–1434.
Ungerstedt, U., 1971, Acta Physiol. Scand. [Suppl.] 367:69–93.
Creese, I., Burt, D. R., and Snyder, S. H., 1977, Science 197:596–598.
Thai, L., Mishra, R. K., Gardner, E. L., Horowitz, S. G., Varmuza, S., and Makman, M. H., 1979, Brain Res. 170:381–386.
Staunton, D. A., Magistretti, P. J., Shoemaker, W. J., and Bloom, F. E., 1982, Brain Res. 232:391–400.
Staunton, D. A., Magistretti, P. J., Shoemaker, W. J., Deyo, S. N., and Bloom, F. E., 1982, Brain Res. 232:401–412.
Creese, I., and Sibley, D. R., 1981, Annu. Rev. Pharmacol. Toxicol. 21:359–391.
Mishra, R. K., Wong, Y.-W., Varmuza, S. L., and Tuff, L., 1978, Life Sci. 23:443–46.
Howlett, D. R., and Nahorski, S. R., 1979, Brain Res. 161:173–178.
Lew, J. Y., Nakamura, S., Battista, A. F., and Goldstein, M., 1979, Commun. Psycho pharmacol. 3:179–83.
Quik, M., and Iversen, L. L., 1978, Naunyn Schmeidebergs Arch. Pharmacol. 304:141–145.
Russell, P., and Madras, B. K., 1983, submitted.
Labrie, F., Di Paolo, T., Raymond, V., Ferland, L., and Beaulieu, M., 1980, Ergot Com pounds and Brain Function: Neuroendocrine and Neuropsychiatric Aspects (M. Goldstein, ed.), Raven Press, New York, p. 217.
Bedard, P. J., Langelier, P., Dankova, J., Villeneuve, A., Di Paolo, T., Barden, N., Labrie, F., Bossier, J. R., and Euvrard, C., 1979, Adv. Neurol. 24:411.
Di Paolo, T., Carmichael, R., Labrie, F., and Raynaud, J.-P., 1979, Mol. Cell. Endocrinol. 16:99–112.
Bedard, P., Dankova, J., Boucher, R., and Langelier, P., 1981, Can. J. Physiol. Pharmacol. 56:538–541.
Di Paolo, T., Payet, P., and Labrie, F., 1981, Eur. J. Pharmacol. 78:105–106.
Hruska, R. E., and Silbergeld, E. K., 1980, Eur. J. Pharmacol. 61:397–400.
Hruska, R. E., Pitman, K. T., Silbergeld, E. K., and Ludmer, L. M., 1982, Life Sci. 30:547–553.
Jenner, P., Rupniak, N. M. J., Hall, M. D., Dyer, R., Leigh, N., and Marsden, C. D., 1981, Eur. J. Pharmacol. 76:31–36.
Bowers, M. B., and Rozitis, A. 1976, Eur. J. Pharmacol. 39:109–115.
Chouinard, G., Annable, L., Jones, B. D., and Collu, R., 1981, Acta Psychiatr. Scand. 64:353–362.
Curry, S. H., Davis, J. M., Marshall, H. L., and Janowsky, D. S., 1970, Arch. Gen. Psychiatry 22:209–215.
Creese, I., and Snyder, S. H., 1977, Nature 270:180–182.
Davis, M. M., Erickson, S., and Dekirmenjian, H., 1978, Psychopharmacology: A Generation of Progress (M. A. Lipton, A. DiMascio, and K. F. Killiam, eds.), Raven Press, New York, pp. 905–916.
Cohen, B. M., Herschel, M., Miller, E. M., Mayberg, H., and Baldessarini, R., 1980, Neuropharmacology 19:663–668.
Cohen, B. M., Herschel, M., and Aoba, A., 1979, Psychiatry Res. 1:199–208.
Rosenblatt, J. E., Pert, C. B., Cobson, J., Van Kammen, D. P., Scott, R., and Bunney, W. E., Jr., 1979, Commun. Psychopharmacol. 3:153–168.
Cohen, B. M., and Lipinski, J. F., 1981, Neuroreceptors-Basic and Clinical Aspects (E. Usdin, W. E. Bunney, and J. M. Davis, eds.), John Wiley & Sons, New York, pp. 199–214.
Uzan, A., Phan, T., and Le Fur, G., 1981, J. Pharm. Pharmacol. 33:102–103.
Le Fur, G., Phan, T., and Uzan, A., 1980, Life Sci. 26:1139–1148.
Le Fur, G., Meininger, V., Phan, T., Gerard, A., Baulac, M., and Uzan, A., 1980, Life Sci. 21: 1587–1591.
Le Fur, G., Phan, T., Canton, T., Tur, C., and Uzan, A., 1981, Life Sci. 29:2737–2749.
Maloteaux, J. M., Waterkein, C., and Laduron, P. M., 1982, Arch. Int. Pharmacodyn. Ther. 258:174–176.
Fleminger, S., Jenner, P., and Marsden, C. D., 1982, J. Pharmacol. 34:658–663.
Madras, B. K., Blaschuk, K., Scully, K., Tang, S. W., 1983, Soc. Neurosci. Abstr. 9:1054.
Strauss, W. L., Ghai, G., Fraser, C. H., and Venter, J. C., 1979, Arch. Biochem. Biophys. 196:566–573.
Ruegg, V. T., Hiller, J. M., and Simon, S. J., 1980, Eur. J. Pharmacol. 64:367–368.
Gorissen, H., and Laduron, P., 1979, Nature 279:72–74.
Madras, B. K., Davis, A., Kunashko, P., and Seeman, P., 1980, Psychopharmacology and Biochemistry of Neurotransmitter Receptors ,(H. I. Yamamura, R. W. Olsen, and E. Usdin, eds.), Elsevier/North Holland, New York, pp. 411–419.
Lerner, M. H., Rosengarten, H., and Friedhoff, A. J., 1981, Life Sci. 29:2367–2374.
Lew, J. Y., Fong, J. C., and Goldstein, M., 1981, Eur. J. Pharmacol. 72:403–405.
Gorissen, H., Ilien, B., Aerts, G., and Laduron, P., 1980, FEBS Lett. 121:133–138.
Clement-Cormier, Y. C., Meyerson, L. R., and Mclsaac, A., 1980, Biochem. Pharmacol. 29:2009–2016.
Gorissen, H., and Laduron, P. M., 1978, Life Sci. 23:575–580.
Chan, B., Madras, B. K., Davis, A., and Seeman, P., 1981, Eur. J. Pharmacol. 74:53–59.
Varmuza, S., and Mishra, R. K., 1981, Pharmacol. Res. Commun. 13:587–605.
Lo, M. M. S., Strittmatter, S. M., and Snyder, S. H., 1982, Proc. Natl. Acad. Sci. 79:680–684.
Chan, B., Seeman, P., Davis, A., and Madras, B. K., 1982, Eur. J. Pharmacol. 81:111–116.
Freedman, J. E., and Snyder, S. H., 1981, J. Biol. Chem. 24:13172–13179.
Lilly, L., Magnan, J., Davis, A., and Seeman, P., 1982, Soc. Neurosci. Abstr. 8:719.
Clement-Cormier, Y. C., and Kendrick, P. E., 1981, Biochem. Pharmacol. 16:2197–2202.
Lilly, L., Davis, A., Madras, B. K., Fraser, C. H., Venter, J. C., and Seeman, P., 1981, Soc. Neurosci. Abstr. 7:10.
Madras, B. K., Davis, L., Lilly, C., Fraser, C., Venter, J. C., and Seeman, P., 1981, Soc. Neurosci. Abstr. 7:10.
Creese, I., Morrow, A. L., Leff, S. E., Sibley, D. R., and Hamblin, M. W., 1982, Int. Rev. Neurobiol. 23:255–301.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer Science+Business Media New York
About this chapter
Cite this chapter
Madras, B.K. (1984). Dopamine. In: Lajtha, A. (eds) Handbook of Neurochemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4568-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-4684-4568-8_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-4570-1
Online ISBN: 978-1-4684-4568-8
eBook Packages: Springer Book Archive